RUA Life Sciences (LON:RUA) Shares Up 13.3% – What’s Next?

RUA Life Sciences plc (LON:RUA)’s stock price was up 13.3% on Wednesday . The company traded as high as GBX 17 and last traded at GBX 17. Approximately 671,315 shares changed hands during trading, an increase of 222% from the average daily volume of 208,548 shares. The stock had previously closed at GBX 15.

RUA Life Sciences Stock Performance

The company has a current ratio of 4.64, a quick ratio of 7.32 and a debt-to-equity ratio of 18.95. The firm has a market capitalization of £10.78 million, a price-to-earnings ratio of -2.61 and a beta of 0.63. The stock’s 50 day moving average price is GBX 13.51 and its two-hundred day moving average price is GBX 12.87.

RUA Life Sciences (LON:RUA) last posted its quarterly earnings results on Friday, January 30th. The company reported GBX (0.23) earnings per share for the quarter. RUA Life Sciences had a negative return on equity of 2.03% and a negative net margin of 3.26%.

About RUA Life Sciences

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.